50
Participants
Start Date
November 19, 2018
Primary Completion Date
December 31, 2021
Study Completion Date
August 8, 2022
Dual Antiplatelet (DAPT) Therapy
"DAPT - one of three (3) antiplatelet medications: ticagrelor (Brilinta), clopidogrel (Plavix) or prasugrel (Effient) with Aspirin.~Aspirin loading dose (LD) = 325 mg. Aspirin maintenance dose (MD) = 81 mg.~P2Y12 Inhibitor Loading Dose (investigator preference):~Clopidogrel 600 mg PO x 1 or 75 mg PO daily x 4; Prasugrel 60 mg PO x 1; Ticagrelor 180 mg PO x 1.~P2Y12 Inhibitor Maintenance Dose (investigator preference):~Clopidogrel 75 mg PO daily; Prasugrel 10 mg PO daily; Ticagrelor 90 mg PO BID."
The Synergy® stent
IVUS guided stent
Northwell Hospital Systems, New York
HonorHealth Research Institute, Scottsdale
Massachusetts General Hospital, Corrigan Minehan Heart Center, Boston
Lead Sponsor
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
HonorHealth Research Institute
OTHER